
Angiotensin receptor antagonists are a relatively new class of cardiovascular drugs for which the clinical application has not yet been completely defined.This article reviews the pharmacology of the various angiotensin receptor antagonists available in Australia, including their mode of action, side effects and potential drug interactions.Angiotensin receptor antagonists are effective drugs for the treatment of mild to moderate hypertension which have a side effect profile similar to placebo. Their role in the management of hypertension remains to be defined, but they are of particular use to patients who are intolerant of ACE inhibitors because of cough. It is uncertain at the present time whether the benefits of ACE inhibition in other disorders such as congestive heart failure and following myocardial infarction will be similar for angiotensin receptor blockers.
Angiotensin II, Biphenyl Compounds, Tetrazoles, Angiotensin-Converting Enzyme Inhibitors, Irbesartan, Benzoates, Losartan, Angiotensin Receptor Antagonists, Hypertension, Humans, Benzimidazoles, Telmisartan, Antihypertensive Agents
Angiotensin II, Biphenyl Compounds, Tetrazoles, Angiotensin-Converting Enzyme Inhibitors, Irbesartan, Benzoates, Losartan, Angiotensin Receptor Antagonists, Hypertension, Humans, Benzimidazoles, Telmisartan, Antihypertensive Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
